Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Addressing The Backlog: Government Shutdown Ends, Now FDA Has To Catch Up

This article was originally published in The Gray Sheet

Executive Summary

After the two-week shutdown, FDA staff are facing a backlog of fiscal year 2014 device submissions. The agency says it is working on a plan and assessing its ability to meet its MDUFA III commitments. The bigger concern, however, may be the regulatory uncertainty created by the short-term deal in Congress.


Related Content

FDA Shutdown Plans For 2015: Same As 2013, But With More People
The Year In Review: Device Trends To Watch In 2014
Medtech 2013: Device Companies Go Where The Growth Is
Editor’s Picks: Notable Gray Sheet Stories From 2013
CMS Director To Diagnostics Industry: Prove Your Cancer Tests Work
Final Home-Use Device Guidance Expected Mostly ‘As Is’ By Year’s End
Device Tax Delay Doesn’t Make The Cut, But Issue Could Be Exhumed In Budget Conference
$18.4 Million In User Fees Left In CDRH’s Coffers, How Long Will It Last?
Shutdown Realities At FDA: No New Submission Reviews, And More
News Briefs: Dx Bill Reintroduced; FDA Questions Guided Therapeutics’ LuViva; Study Milestones





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts